Many pre-clinical and clinical studies have demonstrated the association between TNF-α, IL-1β, and IL-6 and an increasing trend in glycocalyx destruction markers (heparin sulfate, hyaluronan, syndecan-1).
← all excerpts
The Blood-Brain Barrier-A Key Player in Multiple Sclerosis Disease Mechanisms.
1
—
—